Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Calcitriol levels significantly decreased, starting in CKD-3b.

Source: 3.1. Anthropometric, Clinical, and Biochemical Features. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

CKD patients were classified according to their estimated glomerular filtration rate (eGFR) in mL/min/1.73 m2, following the 2017 KDIGO guidelines [], into four groups: CKD-2/3a, 45 to 89; CKD-3b, 30 to 44; CKD-4, 15 to 29; CKD-5, <15.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Non-Invasive Assessment of Vascular Damage Through Pulse Wave Velocity and Superb Microvascular Imaging in Pre-Dialysis Patients

Study design awaiting verification · Biomedicines · 2025

Original publication title

Non-Invasive Assessment of Vascular Damage Through Pulse Wave Velocity and Superb Microvascular Imaging in Pre-Dialysis Patients

Julia Martín-Vírgala; Beatriz Martín-Carro; Sara Fernández-Villabrille; Belinda Fernández-Mariño; Elena Astudillo-Cortés; Minerva Rodríguez-García; Carmen Díaz-Corte; José Luis Fernández-Martín; Carlos Gómez-Alonso; Adriana S. Dusso; Cristina Alonso-Montes; Manuel Naves-Díaz; Sara Panizo; Natalia Carrillo-López

© 2025 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background/Objectives:

Cardiovascular disease is the main cause of morbidity and mortality in Chronic Kidney Disease (CKD), so it is of great importance to find simple and non-invasive tools to detect vascular damage in pre-dialysis CKD patients. This study aimed to assess the applicability of non-invasive techniques to evaluate vascular damage in stages CKD-2 to CKD-5 and its progression after an 18-month follow-up using (A) carotid: femoral pulse wave velocity (PWV) to assess aortic stiffness and (B) Superb Microvascular Imaging (SMI) ultrasound to assess adventitial neovascularization compared with other traditional techniques to evaluate vascular damage, such as carotid intima: media thickness and Kauppila index.

Methods:

The study involved 43 CKD patients in stages CKD-2 to CKD-5 and a group of 38 sex: and age-matched controls, studied at baseline and at an 18-month follow-up. Age, sex, body mass index, arterial pressure, pharmacological treatments, and blood and urinary parameters were collected. Aortic stiffness was determined by carotid: femoral PWV and abdominal aortic calcification was assessed in lateral lumbar X-rays and quantified by the Kauppila index. Carotid intima: media thickness (cIMT), the number of carotid plaques, and adventitial neovascularization were evaluated by SMI.

Results:

Vascular impairment was mostly detected in CKD-4 and CKD-5 stages, with increased aortic stiffness measured by PWV and increased carotid plaques and adventitial neovascularization measured by SMI ultrasound. Furthermore, CKD-5 patients showed greater abdominal aortic calcification. Interestingly, CKD patients displayed a negative correlation between serum soluble Klotho (sKlotho) and cIMT. Finally, CKD patients showed no progression of vascular impairment after the 18-month follow-up, with the exception of carotid plaques.

Conclusions:

Performing non-invasive PWV and SMI ultrasound might be useful to evaluate vascular damage in CKD before entering dialysis, possibly helping to prevent cardiovascular events, although future studies should clarify the use of these techniques in clinical practice.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background/Objectives

Cardiovascular disease is the main cause of morbidity and mortality in Chronic Kidney Disease (CKD), so it is of great importance to find simple and non-invasive tools to detect vascular damage in pre-dialysis CKD patients. This study aimed to assess the applicability of non-invasive techniques to evaluate vascular damage in stages CKD-2 to CKD-5 and its progression after an 18-month follow-up using (A) carotid: femoral pulse wave velocity (PWV) to assess aortic stiffness and (B) Superb Microvascular Imaging (SMI) ultrasound to assess adventitial neovascularization compared with other traditional techniques to evaluate vascular damage, such as carotid intima: media thickness and Kauppila index.

Source: Background/Objectives

Abstract: Results

Vascular impairment was mostly detected in CKD-4 and CKD-5 stages, with increased aortic stiffness measured by PWV and increased carotid plaques and adventitial neovascularization measured by SMI ultrasound. Furthermore, CKD-5 patients showed greater abdominal aortic calcification. Interestingly, CKD patients displayed a negative correlation between serum soluble Klotho (sKlotho) and cIMT. Finally, CKD patients showed no progression of vascular impairment after the 18-month follow-up, with the exception of carotid plaques.

Source: Results:

Abstract: Conclusions

Performing non-invasive PWV and SMI ultrasound might be useful to evaluate vascular damage in CKD before entering dialysis, possibly helping to prevent cardiovascular events, although future studies should clarify the use of these techniques in clinical practice.

Source: Conclusions
Authors’ abstract

Background/Objectives:

Cardiovascular disease is the main cause of morbidity and mortality in Chronic Kidney Disease (CKD), so it is of great importance to find simple and non-invasive tools to detect vascular damage in pre-dialysis CKD patients. This study aimed to assess the applicability of non-invasive techniques to evaluate vascular damage in stages CKD-2 to CKD-5 and its progression after an 18-month follow-up using (A) carotid: femoral pulse wave velocity (PWV) to assess aortic stiffness and (B) Superb Microvascular Imaging (SMI) ultrasound to assess adventitial neovascularization compared with other traditional techniques to evaluate vascular damage, such as carotid intima: media thickness and Kauppila index.

Methods:

The study involved 43 CKD patients in stages CKD-2 to CKD-5 and a group of 38 sex: and age-matched controls, studied at baseline and at an 18-month follow-up. Age, sex, body mass index, arterial pressure, pharmacological treatments, and blood and urinary parameters were collected. Aortic stiffness was determined by carotid: femoral PWV and abdominal aortic calcification was assessed in lateral lumbar X-rays and quantified by the Kauppila index. Carotid intima: media thickness (cIMT), the number of carotid plaques, and adventitial neovascularization were evaluated by SMI.

Results:

Vascular impairment was mostly detected in CKD-4 and CKD-5 stages, with increased aortic stiffness measured by PWV and increased carotid plaques and adventitial neovascularization measured by SMI ultrasound. Furthermore, CKD-5 patients showed greater abdominal aortic calcification. Interestingly, CKD patients displayed a negative correlation between serum soluble Klotho (sKlotho) and cIMT. Finally, CKD patients showed no progression of vascular impairment after the 18-month follow-up, with the exception of carotid plaques.

Conclusions:

Performing non-invasive PWV and SMI ultrasound might be useful to evaluate vascular damage in CKD before entering dialysis, possibly helping to prevent cardiovascular events, although future studies should clarify the use of these techniques in clinical practice.

Publication and source details

Original title: Non-Invasive Assessment of Vascular Damage Through Pulse Wave Velocity and Superb Microvascular Imaging in Pre-Dialysis Patients

Julia Martín-Vírgala; Beatriz Martín-Carro; Sara Fernández-Villabrille; Belinda Fernández-Mariño; Elena Astudillo-Cortés; Minerva Rodríguez-García; Carmen Díaz-Corte; José Luis Fernández-Martín; Carlos Gómez-Alonso; Adriana S. Dusso; Cristina Alonso-Montes; Manuel Naves-Díaz; Sara Panizo; Natalia Carrillo-López

Biomedicines · 2025

* Correspondence: cristinaam.huca@gmail.com (C.A.-M.); mnaves.huca@gmail.com (M.N.-D.); Tel.: +34-985652423 (C.A.-M.); Tel.: +34-985652424 (M.N.-D.)
†

These authors contributed equally to this work.

‡

These authors contributed equally to this work.

© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Instituto de Salud Carlos IIIEuropean UnionPI19/00532PI20/00633PI22/00195PI23/00833ISCIII Retic REDinRENRD16/0009/0017RICORS program to RICORS2040-RENALRD21/0005/0019RD24/0004/0006RD24/0004/0029European Union: NextGenerationEUIDI-2018-000152IDI/2021/000080IDE/2024/000706Fundación Renal Iñigo Álvarez de Toledo (FRIAT)Ministerio de Ciencia, Innovación y UniversidadesFPU2019-00483Gobierno del Principado de AsturiasBP20-081BP19-057Fundación para la Investigación Biosanitaria de Asturias (FINBA)ISCIII: Miguel Servet ProgramEuropean UnionCP23/00105CP23/00058This study was funded by the Instituto de Salud Carlos III (ISCIII, PI19/00532, PI20/00633, PI22/00195, and PI23/00833 co-funded by the European Union), the ISCIII Retic REDinREN (RD16/0009/0017) and RICORS program to RICORS2040-RENAL (RD21/0005/0019, RD24/0004/0006 and RD24/0004/0029) funded by European Union: NextGenerationEU, Mecanismo para la Recuperación y la Resiliencia (MRR), Plan de Ciencia, Tecnología e Innovación 2018 to 2027 del Principado de Asturias (IDI-2018-000152, IDI/2021/000080, IDE/2024/000706); and Fundación Renal Iñigo Álvarez de Toledo (FRIAT). J.M.V was supported by a graduate fellowship from the Ministerio de Ciencia, Innovación y Universidades (FPU program: FPU2019-00483). S.F.-V. and B.M.-C. were supported by a graduate fellowship from the Gobierno del Principado de Asturias (“Severo Ochoa” program: BP20-081 and BP19-057, respectively). C.A-M. was supported by Fundación para la Investigación Biosanitaria de Asturias (FINBA). S.P. and N.C.-L. were supported by the ISCIII: Miguel Servet Program (CP23/00105; CP23/00058, respectively) and co-funded by the European Union.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T06:32:58.344870+00:00

DOI: 10.3390/biomedicines13030621 · PMC11940463